Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and
Rebecca S Arnold1, Ju He, Andrea Remo
1Department of Urology, Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Rd., Building B, Atlanta, GA 30322, USA.
Abstract:
Increased cellular reactive oxygen species (ROS) can act as mitogenic signals in addition to damaging DNA and oxidizing lipids and proteins, implicating ROS in cancer development and progression. To analyze the effects of Nox1 expression and its relation to cellular ROS and signal transduction involved in cellular proliferation, Nox1RNAi constructs were transfected into DU145 prostate cancer cells overexpressing Nox1, causing decreased Nox1 message and protein levels in the Nox1RNAi cell lines. Increased ROS and tumor growth in the Nox1-overexpressing DU145 cells were reversed in the presence of the Nox1RNAi. Analysis and comparison of the message levels in the overexpression and RNAi cells demonstrated that Nox1 overexpression leads to changes in message levels of a variety of proteins including c-fos-induced growth factor, interleukin-8, and Cav-1. Finally, we found that Nox1 protein overexpression is an early event in the development of prostate cancer using a National Cancer Institute prostate cancer tissue microarray (CPCTR). Tumor (86%) was significantly more likely to have Nox1 staining than benign prostate tissue (62%) (P = 0.0001). These studies indicate that Nox1 overexpression may function as a reversible signal for cellular proliferation with relevance for a common human tumor.
Insights
Nox1 overexpression increases reactive oxygen species (ROS) and prostate cancer cell proliferation. Inhibiting Nox1 with RNAi reversed these effects, suggesting Nox1 is a reversible signal in cancer development.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Increased reactive oxygen species (ROS) are linked to cancer development.
- Nox1 (NADPH oxidase 1) role in cellular proliferation and ROS production needs further investigation.
Purpose of the Study:
- To investigate the role of Nox1 in prostate cancer cell proliferation and ROS generation.
- To analyze the relationship between Nox1 expression, ROS levels, and signal transduction pathways.
- To determine if Nox1 overexpression is an early event in prostate cancer development.
Main Methods:
- Transfection of Nox1 RNAi constructs into DU145 prostate cancer cells overexpressing Nox1.
- Measurement of Nox1 message and protein levels.
- Assessment of cellular ROS levels and tumor growth.
- Analysis of message levels for specific proteins (c-fos-induced growth factor, interleukin-8, Cav-1).
- Utilizing a National Cancer Institute prostate cancer tissue microarray (CPCTR) for clinical correlation.
Main Results:
- Nox1 RNAi transfection decreased Nox1 message and protein levels.
- Decreased Nox1 levels reversed increased ROS and tumor growth in Nox1-overexpressing cells.
- Nox1 overexpression altered message levels of c-fos-induced growth factor, interleukin-8, and Cav-1.
- Nox1 protein overexpression was significantly more prevalent in tumor tissue (86%) than benign prostate tissue (62%).
Conclusions:
- Nox1 overexpression acts as a reversible signal for cellular proliferation.
- Nox1 plays a significant role in regulating ROS production and tumor growth in prostate cancer.
- Nox1 overexpression is an early event in prostate cancer development, indicating its clinical relevance.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Cell Specific Gene Expression
Cell Specific Gene Expression

